HEREDITARY ENDOCRINE CANCER: CLINICAL EXOME PANEL (Sec. & CNVs) – 31 genes
LabGenetics
Delivery time
3-4 weeks
Sample
Blood
The Hereditary Endocrine Cancer Panel analyzes genes involved in endocrine tumor predisposition syndromes, including Multiple Endocrine Neoplasia type 1 (MEN1), type 2 (RET), and familial pheochromocytoma/paraganglioma syndromes (SDHB, SDHC, SDHD, MAX, TMEM127, VHL). It also evaluates genes associated with medullary thyroid carcinoma (RET), adrenocortical tumors (TP53, PRKAR1A), familial pituitary tumors (AIP, CDKN1B), and overgrowth syndromes with neoplastic risk (PTEN, TSC1, TSC2). Its clinical utility lies in early diagnosis, individualized management, and family genetic counseling. Genes analyzed: RET, MEN1, SDHB, SDHD, MAX, VHL, PRKAR1A, PTEN, TSC1, TSC2, AIP, CDKN1B, and others. You can consult the complete list of genes analyzed by contacting Genotica.
Other tests
Preventive health test - AboutMe EXOME
545,00€
NEUROFIBROMATOSIS: GENES SMARCB1 Y LZTR1 (NGS-Sec) – ATG Medical
600,00€
Custom sequencing panels (1 to 15 genes)
660,00€